Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Neumann

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Communications Biology|June 5, 2023
Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δFloyd Hassenrück, Maria Farina-Morillas, Lars Neumann, et al.
Chemmedchem|August 12, 2015
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit ListsJohannes Schiebel, Nedyalka Radeva, Helene Köster, et al.
The Journal of Biological Chemistry|July 31, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viabilityBenjamin E L Lauffer, Robert Mintzer, Rina Fong, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) InhibitorsQinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
RSC Medicinal Chemistry|September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimizationR S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Communications Biology|June 5, 2023
Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δFloyd Hassenrück, Maria Farina-Morillas, Lars Neumann, et al.
Chemmedchem|August 12, 2015
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit ListsJohannes Schiebel, Nedyalka Radeva, Helene Köster, et al.
The Journal of Biological Chemistry|July 31, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viabilityBenjamin E L Lauffer, Robert Mintzer, Rina Fong, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) InhibitorsQinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
RSC Medicinal Chemistry|September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimizationR S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Pageof 4